One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

Saved in:
Bibliographic Details
Published inESMO open Vol. 8; no. 1; p. 100785
Main Authors van der Veldt, A.A.M., Oosting, S.F., Fehrmann, R.S.N., GeurtsvanKessel, C.H., van Binnendijk, R.S., Dingemans, A.-M.C., Smit, E.F., Hiltermann, T.J.N., Hartog, G. den, Jalving, M., Westphal, T.T., Bhattacharya, A., de Wilt, F., Ernst, S.M., Boerma, A., van Zijl, L., Rimmelzwaan, G.F., Kvistborg, P., van Els, C.A.C.M., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.E.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2023
The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology
Subjects
Breakthrough Infections
Correspondence
COVID-19
Humans
Neoplasms
Patients
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
Contributed equally
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2023.100785